Liver Disease: Clinical Trials

15 trials for Liver Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 3 terminated, 2 unknown, 1 withdrawn. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Completed 9, Terminated 3, Unknown 2, Withdrawn 1

Follow Liver Disease: new trials by email Literature Review of Liver Disease trials Research Report on Liver Disease

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
deLIVER: Direct Acting Antiviral Effects on the Liver
Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX], Sofosbuvir/Velpatasvir (SOF/VEL) - HCV Coinfection, Liver Disease
Phase 4CompletedJohns Hopkins University152017-01-012022-02-24
Minocycline Administration During Human Liver Transplantation
Minocycline (yes/no), Placebo - Liver Disease
Phase 4WithdrawnMedical University of South Carolina2016-03-012018-06-18
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
sofosbuvir/ledipasvir, sofosbuvir, Ribavirin - Liver Disease
Phase 4TerminatedUniversity of Texas Southwestern Medical Center12016-02-252019-01-08
Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure
Caspofungin 70 mg - Bacterial Infections and Mycoses, Liver Disease
Phase 4CompletedErasme University Hospital202013-09-012019-02-15
Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease
Fresh Frozen Plasma, Pre-Transfusion International Normalized Ratio (INR), Post-Transfusion International Normalized Ratio (INR) - Liver Disease
Phase 4CompletedUniversity of Colorado, Denver502012-06-272019-10-29
Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis
Metformin, Siliphos+ Selenium - Methionine + Alpha Lipoic Acid - Liver Disease
Phase 4CompletedInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran502011-11-012014-08-20
Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients
Anidulafungin, Liposomal amphotericin B - Liver Disease, Fungal Infection
Phase 4CompletedFundacion SEIMC-GESIDA612011-11-012014-05-30
Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus
Tacrolimus and Sirolimus, Tacrolimus - Liver Disease
Phase 4CompletedFoundation for Liver Research1962011-02-072022-03-18
Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections
Pioglitazone, Placebo - HIV, Hepatitis C
Phase 4TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)132008-08-012016-12-09
A Study of Thymoglobulin and Tacrolimus in Liver Transplant
anti-thymocyte globulin (rabbit), tacrolimus - Liver Transplantation, Liver Disease
Phase 4UnknownUniversity of Nebraska1002007-12-012007-11-28
Effect of Preoperative Supplementation in Insulin Resistance
Aminolevan EN, Placebo - Liver Disease
Phase 4CompletedKochi University262007-04-012008-04-14
Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation
mycophenolate mofetil - Liver Disease
Phase 4CompletedAlbert Einstein Healthcare Network192006-08-012013-08-02
Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
morphine and glucagon - Liver Disease
Phase 4UnknownNational Taiwan University Hospital1002005-09-012005-11-28
A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices
Variceal band ligation, cyanoacrylate injection - Liver Disease
Phase 4CompletedFederal University of São Paulo382004-11-012008-12-01
Orthotopic Liver Transplantation Using a Living Donor
donor right hepatic lobectomy - Liver Disease, Liver Neoplasms
Phase 4TerminatedUniversity of Chicago202000-04-012013-09-27

Narrower conditions

Liver Diseases (15)  ·  Fatty Liver (2)  ·  Hepatitis C (2)  ·  Bacterial Infections and Mycoses (1)  ·  End Stage Liver Disease (1)  ·  Esophageal and Gastric Varices (1)  ·  Liver Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Mycoses (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Digestive System Diseases (15)  ·  Infections (4)  ·  Blood-Borne Infections (2)  ·  Communicable Diseases (2)  ·  Flaviviridae Infections (2)  ·  Hepatitis (2)  ·  Hepatitis, Viral, Human (2)  ·  Neoplasms (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)  ·  Bacterial Infections and Mycoses (1)  ·  Digestive System Neoplasms (1)  ·  Esophageal Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Hemic and Lymphatic Diseases (1)

Interventions

Sofosbuvir (2)  ·  Tacrolimus (2)  ·  Anidulafungin (1)  ·  Antilymphocyte Serum (1)  ·  Caspofungin (1)  ·  Cyanoacrylates (1)  ·  Glucagon (1)  ·  Metformin (1)  ·  Minocycline (1)  ·  Morphine (1)  ·  Mycophenolic Acid (1)  ·  Pioglitazone (1)  ·  Ribavirin (1)  ·  Rosiglitazone (1)  ·  Sirolimus (1)

Sponsors

Albert Einstein Healthcare Network (1)  ·  Erasme University Hospital (1)  ·  Federal University of São Paulo (1)  ·  Foundation for Liver Research (1)  ·  Fundacion SEIMC-GESIDA (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  Johns Hopkins University (1)  ·  Kochi University (1)  ·  Medical University of South Carolina (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  National Taiwan University Hospital (1)  ·  University of Chicago (1)  ·  University of Colorado, Denver (1)  ·  University of Nebraska (1)  ·  University of Texas Southwestern Medical Center (1)

Countries

United States (8)  ·  Belgium (1)  ·  Brazil (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Aldo Torre Delgadillo, M.D., M. Sc. (1)  ·  Asuncion Moreno, MD (1)  ·  Carlos Cervera, MD (1)  ·  Colleen M Hadigan, M.D. (1)  ·  David J Reich, MD (1)  ·  Herold J Metselaar, MD PhD (1)  ·  Hon-Man Liu, MD (1)  ·  J. Michael Millis, MD (1)  ·  Kenneth Chavin, MD, PhD (1)  ·  Mamta K. Jain, MD (1)  ·  Marc Moss, MD (1)  ·  Mark Sulkowski, M.D. (1)  ·  Samuel C Berngard, MD (1)

Results publications

PMID 29860319, PMID 36722133, PMID 39656808